跳至主要内容
临床试验/NCT00506480
NCT00506480Unknown不适用

Phase 1 Study of Endometrial Markers of Endometrial Receptivity in Oocyte Donation

Hadassah Medical Organization0 个研究点目标入组 100 人开始时间: 2007年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
100
主要终点
embryo implantation

研究概览

简要总结

The purpose of this study is to determine whether endometrial receptivity markers obtained by endometrial sampling are effective in prediction of in vivo human embryo implantation.

详细描述

Since the introduction of In vitro fertilization (IVF), substantial improvements have been developed in ovulation induction, oocyte retrieval, fertilization capability and embryonic development. However, the end point which is to improve implantation and pregnancy rates after transferring embryos, remains below physiological expectations. It has been estimated that clinical implantation in the human is efficient in no more than 30% of cases considering that only one embryo is present in natural cycles, which gives us a 30% implantation rate.

A frequent pitfall found in the literature is the consideration that implantation is the result of good embryonic quality. Although this is completely true, it is not the only truth because the maternal endometrium is at least of equal relevance. In ovum donation, the endometrial factor could also be improved by individualizing the implantation window in each patient. In this proposed research we will analyze suggested markers of endometrial receptivity in order to optimize human implantation in patients undergoing assisted reproductive technologies focusing on improving endometrial receptivity in IVF and ovum donation patients.

研究设计

研究类型
Interventional
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 51 Years(Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Patients scheduled for IVF or OD

排除标准

  • •Cervical stenosis

研究组 & 干预措施

OD

Experimental

patients artificially prepared for OD will undergo a mock cycle consisting of estrogen and later by progesterone. a pipelle sample will be taken after 6 days of progesterone supplementation.

干预措施: endometrial sampling (Procedure)

IVF

Experimental

A pipelle sample will be taken on day 21 of the cycle before administration of GNRHa. Exact timing will be performed by counting 7 days from the LH surge.

干预措施: endometrial sampling (Procedure)

结局指标

主要结局

embryo implantation

时间窗: 1 MONTH

次要结局

未报告次要终点

研究者

申办方类型
Other

相似试验